Data / Form D filings / Eos SENOLYTIX, Inc.
Eos SENOLYTIX, Inc.: Form D filings
Eos SENOLYTIX, Inc., a pharmaceuticals company in Houston, TX, filed 2 Form D notices with the SEC in 2026. The latest, on August 27, 2026, reports $750,000 sold of a $25 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2710 REED ROAD SUITE 160, Houston, TX, 77051
- Phone
- (305) 809-6920
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2129803
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Amendment | $25,000,000 | $750,000 | $24,250,000 | 2 | Jun 4, 2026 | sec.gov |
| Jun 12, 2026 | New notice | $25,000,000 | $750,000 | $24,250,000 | 2 | Jun 4, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Mark Slawin | Executive Officer, Director | |
| Frank Bartlett McGuyer | Director | |
| Jerold Winograd | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Aug 24, 2026 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Eos SENOLYTIX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.